QS Investors’s Athenahealth, Inc. ATHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-848
Closed -$112K 1956
2018
Q4
$112K Hold
848
﹤0.01% 1303
2018
Q3
$113K Hold
848
﹤0.01% 1369
2018
Q2
$135K Hold
848
﹤0.01% 1336
2018
Q1
$121K Sell
848
-800
-49% -$109K ﹤0.01% 1336
2017
Q4
$219K Hold
1,648
﹤0.01% 1170
2017
Q3
$205K Hold
1,648
﹤0.01% 1215
2017
Q2
$232K Buy
1,648
+900
+120% +$112K ﹤0.01% 1151
2017
Q1
$84K Buy
748
+700
+1,458% +$81.6K ﹤0.01% 1423
2016
Q4
$5K Hold
48
﹤0.01% 1480
2016
Q3
$6K Hold
48
﹤0.01% 1450
2016
Q2
$7K Hold
48
﹤0.01% 1459
2016
Q1
$7K Buy
48
+8
+20% +$1.1K ﹤0.01% 1453
2015
Q4
$6K Buy
+40
New +$6.18K ﹤0.01% 1461

QS Investors's ATHN Position: Q1 2019 in Review

QS Investors sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 848 shares — an estimated $112K sold.

QS Investors first reported a position in ATHN in Q4 2015 and held it in 13 quarters. The position peaked at $232K in Q2 2017. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.

  • QS Investors reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
  • QS Investors sold 848 Athenahealth, Inc. shares in Q1 2019, an estimated $112K.
  • QS Investors first reported a position in Athenahealth, Inc. in Q4 2015 and held it in 13 quarters.
  • QS Investors's Athenahealth, Inc. position peaked at $232K in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.

Based on QS Investors's 13F filing for Q1 2019, filed 15 May 2019.